Early Life and Education
Mario Germano Giuliani, born in 1971, holds Swiss citizenship. He earned a Bachelor of Arts degree in Economics from the Catholic University of the Sacred Heart. He later obtained a Master's degree in Corporate Finance from Università Commerciale Luigi Bocconi in Milan, Italy.
Rise to Success
Giuliani's primary source of wealth is his involvement in the pharmaceutical industry, particularly as a healthcare investor. He owns an 8% stake in Royalty Pharma, which went public in 2020. Royalty Pharma is the world's largest acquirer of pharmaceutical royalties. He and his brother, Giammaria, also own stakes in Swiss investment company HBM Healthcare Investments and a number of biotech firms in the U.S. Additionally, the brothers share ownership of their family's pharmaceutical company, Giuliani, founded in Milan, Italy in 1889.
Key Business Strategies
Giuliani's investment strategy focuses on the healthcare sector, specifically on pharmaceutical royalties. Royalty Pharma collects revenue from blockbuster drugs like Humira, Imbruvica, Lyrica, and Xtandi. His strategy involves identifying and investing in promising pharmaceutical assets to generate significant returns.
Philanthropy
Information on specific philanthropy amounts and initiatives are unavailable based on the current search results.
